R&D Breaking into the global pharmaceutical market In 2022, pharma is truly a global industry, and innovation can come from anywhere.
Partner Content Partner Content Registration opens for SMi’s 4th Annual Ophthalmic Drugs Con... Registration opens for Ophthalmic Drugs Conference
News BioMarin ends year with $4.8bn play for Amicus BioMarin takes a leap towards its $4bn revenue target with a $4.8bn deal to acquire Amicus, which has two rare disease therapies on the market.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
